These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 31303559)
1. Association of Low Socioeconomic Status With Adverse Prostate Cancer Pathology Among African American Men Who Underwent Radical Prostatectomy. Weprin SA; Parker DC; Jones JD; Kaplan JR; Giusto LL; Mydlo JH; Yu SS; Lee DI; Eun DD; Reese AC Clin Genitourin Cancer; 2019 Oct; 17(5):e1054-e1059. PubMed ID: 31303559 [TBL] [Abstract][Full Text] [Related]
2. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men. Yamoah K; Deville C; Vapiwala N; Spangler E; Zeigler-Johnson CM; Malkowicz B; Lee DI; Kattan M; Dicker AP; Rebbeck TR Urol Oncol; 2015 Feb; 33(2):70.e15-22. PubMed ID: 25304288 [TBL] [Abstract][Full Text] [Related]
3. African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? Sundi D; Ross AE; Humphreys EB; Han M; Partin AW; Carter HB; Schaeffer EM J Clin Oncol; 2013 Aug; 31(24):2991-7. PubMed ID: 23775960 [TBL] [Abstract][Full Text] [Related]
4. Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up. Faisal FA; Sundi D; Cooper JL; Humphreys EB; Partin AW; Han M; Ross AE; Schaeffer EM Urology; 2014 Dec; 84(6):1434-41. PubMed ID: 25432835 [TBL] [Abstract][Full Text] [Related]
5. A Population-Based Study of Men With Low-Volume Low-Risk Prostate Cancer: Does African-American Race Predict for More Aggressive Disease? Schreiber D; Chhabra A; Rineer J; Weedon J; Schwartz D Clin Genitourin Cancer; 2015 Aug; 13(4):e259-e264. PubMed ID: 25777681 [TBL] [Abstract][Full Text] [Related]
6. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer. Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115 [TBL] [Abstract][Full Text] [Related]
7. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA. Lediju O; Ikuemonisan J; Salami SS; Adejoro O J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310 [TBL] [Abstract][Full Text] [Related]
8. Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy. Aminsharifi A; Schulman A; Howard LE; Tay KJ; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ; Polascik TJ Cancer; 2019 Sep; 125(17):3025-3032. PubMed ID: 31042315 [TBL] [Abstract][Full Text] [Related]
9. African-american race is a predictor of seminal vesicle invasion after radical prostatectomy. Yamoah K; Walker A; Spangler E; Zeigler-Johnson CM; Malkowicz B; Lee DI; Dicker AP; Rebbeck TR; Lal P Clin Genitourin Cancer; 2015 Apr; 13(2):e65-72. PubMed ID: 25450037 [TBL] [Abstract][Full Text] [Related]
10. Multivariate analysis of race and adverse pathologic findings after radical prostatectomy. Freedland SJ; Dorey F; Aronson WJ Urology; 2000 Nov; 56(5):807-11. PubMed ID: 11068307 [TBL] [Abstract][Full Text] [Related]
11. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics. Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973 [TBL] [Abstract][Full Text] [Related]
12. Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy. Jeong IG; Dajani D; Verghese M; Hwang J; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY Urol Oncol; 2016 Jan; 34(1):3.e9-14. PubMed ID: 26345648 [TBL] [Abstract][Full Text] [Related]
13. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate. Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563 [TBL] [Abstract][Full Text] [Related]
14. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison. Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067 [TBL] [Abstract][Full Text] [Related]
15. Effect of race and socioeconomic status on surgical margins and biochemical outcomes in an equal-access health care setting: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Chu DI; Moreira DM; Gerber L; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ Cancer; 2012 Oct; 118(20):4999-5007. PubMed ID: 22415377 [TBL] [Abstract][Full Text] [Related]
16. A 17-Gene Panel Genomic Prostate Score Has Similar Predictive Accuracy for Adverse Pathology at Radical Prostatectomy in African American and European American Men. Murphy AB; Carbunaru S; Nettey OS; Gornbein C; Dixon MA; Macias V; Sharifi R; Kittles RA; Yang X; Kajdacsy-Balla A; Gann P Urology; 2020 Aug; 142():166-173. PubMed ID: 32277993 [TBL] [Abstract][Full Text] [Related]
17. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen. Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974 [TBL] [Abstract][Full Text] [Related]
18. Commentary on "African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?" Sundi D, Ross AE, Humphreys EB, Han M, Partin AW, Carter HB, Schaeffer EM, Johns Hopkins University, Baltimore, MD. J Clin Oncol 2013; 31(24):2991-7. [Epub 2013 Jun 17]. doi: 10.1200/JCO.2012.47.0302. Eggener S Urol Oncol; 2014 Aug; 32(6):936. PubMed ID: 25087674 [TBL] [Abstract][Full Text] [Related]
19. Is Hispanic race an independent risk factor for pathological stage in patients undergoing radical prostatectomy? Lam JS; Desai M; Mansukhani MM; Benson MC; Goluboff ET J Urol; 2003 Dec; 170(6 Pt 1):2288-91. PubMed ID: 14634398 [TBL] [Abstract][Full Text] [Related]
20. Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Tarman GJ; Kane CJ; Moul JW; Thrasher JB; Foley JP; Wilhite D; Riffenburgh RH; Amling CL Urology; 2000 Dec; 56(6):1016-20. PubMed ID: 11113750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]